当前位置： SCI文献检索 > BMC PUBLIC HEALTH期刊下所有文献 > Costs associated with delivering HPV vaccination in the context of the first year demonstration programme in southern Mozambique.

Costs associated with delivering HPV vaccination in the context of the first year demonstration programme in southern Mozambique.

Abstract：

BACKGROUND:In Mozambique cervical cancer is a public health threat, due to its high incidence and limited access to early diagnosis of precancerous lesions. International organisations are supporting the introduction of human papillomavirus (HPV) vaccines in low- and middle-income countries. Some of these countries recently conducted demonstration programmes, which included evaluation of acceptability, coverage, and practicality of implementation and of integration in existing programmes. Information on costs of delivering the vaccine is needed to overcome the challenges of reaching vaccine potential recipients in rural and remote areas. METHODS:We estimated the financial and economic costs of delivering HPV vaccination to ten-year-old girls at schools for the first vaccination cycle of the demonstration programme in the Manhiça district (southern Mozambique), delivered throughout 2014. We also estimated costs of an alternative scenario with a reduced number of doses and personnel, which was analogous to the second vaccination cycle delivered throughout 2015. Cost estimates followed a micro-costing approach and included interviews with key informants at different administrative levels through the administration of standard questionnaires developed by the World Health Organisation. RESULTS:Considering only data from the first vaccination cycle (2014), which consisted in the administration of three doses, the average economic cost was US$17.59 per dose and US$52.29 per fully-immunised girl (FIG). Financial cost per dose (US$6.07) and per FIG (US$17.95) were substantially lower. The economic cost was US$15.53 per dose and US$31.14 per FIG when estimating an alternative cost scenario with reduced number of doses and personnel. CONCLUSIONS:The average economic cost per dose was lower than the ones recently reported for low- and middle-income countries. However, our estimation of the financial cost per FIG was higher than the ones observed elsewhere (ranging from US$2.49 in India to US$20.36 in Vietnam) due to the high percentage of out-of-school girls which, reduced vaccine coverage and, therefore, reduced the denominator. Due to budget constraints, if Mozambique is to implement nation-wide HPV vaccination targeted to ten-year-old girls at schools, a reduction in personnel costs should be operated either by restricting the outreach vaccinator team or the number of supervision visits.

journal_name

BMC Public Health

journal_title

BMC public health

authors

Alonso S,Cambaco O,Maússe Y,Matsinhe G,Macete E,Menéndez C,Sicuri E,Sevene E,Munguambe K

doi

10.1186/s12889-019-7338-4

subject

Has Abstract

pub_date

2019-08-01 00:00:00

pages

1031

issue

issn

1471-2458

pii

10.1186/s12889-019-7338-4

journal_volume

pub_type

杂志文章

在线工具

Costs associated with delivering HPV vaccination in the context of the first year demonstration programme in southern Mozambique.